SCHEMBL12377416

SCHEMBL12377416

C=C(C)c1ccc2c(-c3cccc4c3oc3ccccc34)c3cc(C(=C)C)ccc3c(-c3ccc4ccccc4c3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
PRKDC P78527 4/20 0.34
GGPS1 O95749 1/20 0.34
HDAC8 Q9BY41 2/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1B1 Q16678 1/20 0.33
PRMT5 O14744 1/20 0.32
WDR77 Q9BQA1 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
GPR84 Q9NQS5 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC2 Q92769 1/20 0.32
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
AVPR1A P37288 1/20 0.30
PIK3CD O00329 1/20 0.30
PIK3CB P42338 1/20 0.30
HSP90AA1 P07900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12229294 0.93 ALOX5 (0.38) ALOX5PRKDCGGPS1GPR84
SCHEMBL13860947 0.89 ALOX5 (0.47) ALOX5PRKDCGGPS1HDAC8NPC1
SCHEMBL12377417 0.86 ALOX5 (0.41) ALOX5PRKDCGGPS1HDAC8NPC1
SCHEMBL12377414 0.85 ALOX5 (0.41) ALOX5PRKDCGGPS1HDAC8NPC1
SCHEMBL126383 0.85 ALOX5 (0.52) ALOX5PRKDCGGPS1HDAC8CYP1A1
SCHEMBL24663128 0.84 ALOX5 (0.49) ALOX5PRKDCGGPS1HDAC8CYP1A1
SCHEMBL13488345 0.84 ALOX5 (0.44) ALOX5PRKDCGGPS1CYP1A1CYP1B1
SCHEMBL22916860 0.83 ALOX5 (0.50) ALOX5PRKDCGGPS1HDAC8CYP1A1
SCHEMBL12577592 0.83 ALOX5 (0.50) ALOX5PRKDCGGPS1HDAC8CYP1A1
SCHEMBL21450725 0.83 ALOX5 (0.55) ALOX5PRKDCGGPS1HDAC8CYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989644-B2 Electroluminescent device BASF SE (DE) 2011-08-02 US disclosed
US-20090131673-A1 Electroluminescent Device UDC IRELAND LIMITED (IE) 2009-05-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131673-A1 Electroluminescent Device DDT, CD99, EED ALOX5 741/4885PRKDC 1787/4885GGPS1 2096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.